Form 4 holding
Director
Spero Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 7,500
- Estimated value
- $8,400
- Report date
- 17 Aug 2021
- Price
- $1.12
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount